Clinical trial
Effective Measurement of Risperidone Treatment Outcome for Persons With…
NCT00204347 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00204347 |
|---|---|
| Title | Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder |
| Official title | Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder: The UAB Borderline Rating Scale (BRS) |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | Janssen Pharmaceutica Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Borderline Personality Disorder |
| Intervention type | Drug |
| Interventions | risperidone |
| Enrollment | 20 |
| Start date | Jul 1, 2003 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Jun 10, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: